CIPLA
Cipla Gets Final Approval for Generic Version of GlaxoSmithKline's IMITREX
Cost Effective Process Technology of Favipiravir Developed by CSIR Used by M/s Cipla Ltd.
Cipla Signed Licensing Pact with Gilead to Manufacture & Distribute Remdesivir